Cargando…
Transgenic mouse model of IgM(+) lymphoproliferative disease mimicking Waldenström macroglobulinemia
Waldenström macroglobulinemia (WM) is a low-grade incurable immunoglobulin M(+) (IgM(+)) lymphoplasmacytic lymphoma for which a genetically engineered mouse model of de novo tumor development is lacking. On the basis of evidence that the pro-inflammatory cytokine, interleukin 6 (IL6), and the surviv...
Autores principales: | Tompkins, V S, Sompallae, R, Rosean, T R, Walsh, S, Acevedo, M, Kovalchuk, A L, Han, S-S, Jing, X, Holman, C, Rehg, J E, Herms, S, Sunderland, J S, Morse, H C, Janz, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148059/ https://www.ncbi.nlm.nih.gov/pubmed/27813533 http://dx.doi.org/10.1038/bcj.2016.95 |
Ejemplares similares
-
A rare case report of waldenström macroglobulinemia converted to serum low IgM
por: Xiang, Yuan, et al.
Publicado: (2023) -
Discrete renal deposition of IgM heavy chain and κ light chain in Waldenström macroglobulinemia (IgM-κ)
por: Komatsuda, Atsushi, et al.
Publicado: (2012) -
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
por: Varettoni, Marzia, et al.
Publicado: (2017) -
Targeting IL-6 receptor reduces IgM levels and tumor growth in Waldenström macroglobulinemia
por: Han, Weiguo, et al.
Publicado: (2019) -
Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance
por: Drandi, Daniela, et al.
Publicado: (2022)